Sanni Ruotsalainen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sanni Ruotsalainen has a total of 790 co-authors. Here are the top co-authors by number of shared publications:
- Samuli Ripatti
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
20 shared publications - Aarno Palotie
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland
16 shared publications - Matti Pirinen
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
10 shared publications Finn Gen
9 shared publications- Veikko Salomaa
Department of Internal Medicine, University of Turku, Turku, Finland
9 shared publications Juha Karjalainen
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
7 shared publications
Latest Publications
- 30 September 2026
- Published by Springer Nature in Nature
- Vol. 659 (8141) , 729-743
Population-scale immune multiome atlas reveals regulatory disease mechanisms
Most disease-associated genetic variants lie in non-coding regions1,2, yet mechanistic insights are limited by the lack of an empirical framework for characterizing the molecular consequences of regulatory variation. Single-cell molecular quantitative trait locus (QTL) mapping3,4 connects variants to gene regulation but lacks the power and simultaneous measurements to trace mechanisms from chromatin to expression5. Here we show that population-scale simultaneous profiling of chromatin accessibility and gene expression across immune cells reveals regulatory architectures connecting variants to disease. From paired single-nucleus assay for transposase-accessible chromatin-sequencing (snATAC–seq) and single-nucleus RNA-sequencing (snRNA-seq) analysis of 10 million peripheral blood mononuclear cells in 1,108 Finnish individuals6, we identify 51,083 cis-expression QTLs for 20,829 genes, 338,100 cis-chromatin accessibility QTLs for 210,584 peaks, 119,094 putative causal variants and 593,765 peak–gene links. Variants completing chromatin-to-expression cascades show twice the disease colocalization of chromatin-only effects, with massively parallel reporter assays7 validating 10,428 fine-mapped molecular QTLs. At evolutionarily constrained genes, we identify multilayered regulatory buffering, in which chromatin accessibility changes occur with normal effect sizes, but transmission to expression is attenuated through weaker, more numerous enhancer–gene links. This reconciles why disease variants preferentially target constrained genes despite apparent expression QTL depletion8,9,10,11. Analysis using a massively parallel reporter assay7 confirms that this buffering acts downstream of the regulatory element, with constraint operating at the chromatin-to-expression interface rather than on intrinsic cis-regulatory activity. Our atlas provides testable hypotheses for over half of immune disease associations, illustrated by cascades at autoimmune loci (TICAM1 and RHOH) and Finnish-enriched variants (TNRC18 and IL21R).
- 30 September 2026
- Published by Springer Nature in Nature
- Vol. 659 (8141) , 729-743
Population-scale immune multiome atlas reveals regulatory disease mechanisms
Most disease-associated genetic variants lie in non-coding regions1,2, yet mechanistic insights are limited by the lack of an empirical framework for characterizing the molecular consequences of regulatory variation. Single-cell molecular quantitative trait locus (QTL) mapping3,4 connects variants to gene regulation but lacks the power and simultaneous measurements to trace mechanisms from chromatin to expression5. Here we show that population-scale simultaneous profiling of chromatin accessibility and gene expression across immune cells reveals regulatory architectures connecting variants to disease. From paired single-nucleus assay for transposase-accessible chromatin-sequencing (snATAC–seq) and single-nucleus RNA-sequencing (snRNA-seq) analysis of 10 million peripheral blood mononuclear cells in 1,108 Finnish individuals6, we identify 51,083 cis-expression QTLs for 20,829 genes, 338,100 cis-chromatin accessibility QTLs for 210,584 peaks, 119,094 putative causal variants and 593,765 peak–gene links. Variants completing chromatin-to-expression cascades show twice the disease colocalization of chromatin-only effects, with massively parallel reporter assays7 validating 10,428 fine-mapped molecular QTLs. At evolutionarily constrained genes, we identify multilayered regulatory buffering, in which chromatin accessibility changes occur with normal effect sizes, but transmission to expression is attenuated through weaker, more numerous enhancer–gene links. This reconciles why disease variants preferentially target constrained genes despite apparent expression QTL depletion8,9,10,11. Analysis using a massively parallel reporter assay7 confirms that this buffering acts downstream of the regulatory element, with constraint operating at the chromatin-to-expression interface rather than on intrinsic cis-regulatory activity. Our atlas provides testable hypotheses for over half of immune disease associations, illustrated by cascades at autoimmune loci (TICAM1 and RHOH) and Finnish-enriched variants (TNRC18 and IL21R).
- Open Access
- 19 November 2024
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 111 (12) , 2789-2798
Inherited infertility: Mapping loci associated with impaired female reproduction
- 19 November 2024
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 111 (12) , 2789-2798
Open AccessInherited infertility: Mapping loci associated with impaired female reproduction
- Open Access
- 8 September 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Chat-Based Digital Clinic Encourages Individuals at High Risk of Cardiovascular Disease to Contact Physician Following Digital Risk Communication (Preprint)
BACKGROUND Digital communication of cardiovascular disease (CVD) risk directly to individuals can promote preventive actions. We have previously shown that communicating CVD-risk, including polygenic risk information through a web portal leads to about 20 % of individuals at high risk of CVD contacting a physician. OBJECTIVE To test if mobile-optimised risk communication combined with a chat-based digital clinic for consulting a physician would increase preventive actions among individuals at high risk of CVD. METHODS We studied N=4808 Finnish individuals, aged 40-60 years with no history of cardiovascular disease and at least one major risk factor for CVD. The digital clinic group (N=1050) received the intervention. Matched controls (N=3758) were sampled from our previous study, and they received CVD-risk information without chat-based access to health professionals. RESULTS Compared to the matched controls, individuals in the digital clinic group were more likely to seek contact with a physician following digital risk communication (36.4 % vs. 18.6 % of individuals at high risk sought contact; P=.03). Majority of participants found the risk communication and chat-based digital consultation easy to understand (95 %) and useful (93 %). CONCLUSIONS Mobile-optimised CVD-risk communication followed by an easy access to physician’s consultation considerably elevated the likelihood of contacting physician compared to only communicating the individual’s risk. Further research is needed to target the health care resources optimally in this mobile setting to the individuals most in need for risk-lowering actions.
- 8 September 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessChat-Based Digital Clinic Encourages Individuals at High Risk of Cardiovascular Disease to Contact Physician Following Digital Risk Communication (Preprint)
BACKGROUND Digital communication of cardiovascular disease (CVD) risk directly to individuals can promote preventive actions. We have previously shown that communicating CVD-risk, including polygenic risk information through a web portal leads to about 20 % of individuals at high risk of CVD contacting a physician. OBJECTIVE To test if mobile-optimised risk communication combined with a chat-based digital clinic for consulting a physician would increase preventive actions among individuals at high risk of CVD. METHODS We studied N=4808 Finnish individuals, aged 40-60 years with no history of cardiovascular disease and at least one major risk factor for CVD. The digital clinic group (N=1050) received the intervention. Matched controls (N=3758) were sampled from our previous study, and they received CVD-risk information without chat-based access to health professionals. RESULTS Compared to the matched controls, individuals in the digital clinic group were more likely to seek contact with a physician following digital risk communication (36.4 % vs. 18.6 % of individuals at high risk sought contact; P=.03). Majority of participants found the risk communication and chat-based digital consultation easy to understand (95 %) and useful (93 %). CONCLUSIONS Mobile-optimised CVD-risk communication followed by an easy access to physician’s consultation considerably elevated the likelihood of contacting physician compared to only communicating the individual’s risk. Further research is needed to target the health care resources optimally in this mobile setting to the individuals most in need for risk-lowering actions.
- Open Access
Inherited infertility - mapping loci associated with impaired female reproduction
Female infertility is a common and complex health problem affecting millions of women worldwide. While multiple factors can contribute to this condition, the underlying cause remains elusive in up to 15-30% of cases. In our large genome-wide association study (GWAS) of 22,849 women with infertility and 198,989 controls from the Finnish population cohort FinnGen, we unveil a unique landscape of genetic factors associated with the disease. Our recessive analysis identified a low-frequency stop-gained mutation in TBPL2 (p.Arg331Ter; minor allele frequency (MAF) = 1.2%) with an impact comparable to highly penetrant monogenic mutations (OR = 650, p = 4.1 ×10 -25 ). While previous studies have linked the homologous gene to anovulation and sterility in knockout mice, the severe consequence of the p.Arg331Ter mutation was evidenced by homozygous carriers having significantly fewer offspring (average of 0.16) compared to women belonging to the other genotype groups (average of 1.75 offspring, p = 1.4×10 -15 ). Notably, all homozygous women who had given birth had received infertility therapy. Moreover, our age-stratified analyses identified three additional genome-wide significant loci. Two loci were associated with early-onset disease (infertility diagnosed before age 30), located near CHEK2 and within the major histocompatibility complex (MHC)-region. The third locus, associated with late-onset disease, had its lead SNP located in an intron of a lncRNA gene. Taken together, our data highlight the significance of rare recessive alleles in shaping female infertility risk. The results further provide evidence supporting specific age-dependent mechanisms underlying this complex disorder.
Open AccessInherited infertility - mapping loci associated with impaired female reproduction
Female infertility is a common and complex health problem affecting millions of women worldwide. While multiple factors can contribute to this condition, the underlying cause remains elusive in up to 15-30% of cases. In our large genome-wide association study (GWAS) of 22,849 women with infertility and 198,989 controls from the Finnish population cohort FinnGen, we unveil a unique landscape of genetic factors associated with the disease. Our recessive analysis identified a low-frequency stop-gained mutation in TBPL2 (p.Arg331Ter; minor allele frequency (MAF) = 1.2%) with an impact comparable to highly penetrant monogenic mutations (OR = 650, p = 4.1 ×10 -25 ). While previous studies have linked the homologous gene to anovulation and sterility in knockout mice, the severe consequence of the p.Arg331Ter mutation was evidenced by homozygous carriers having significantly fewer offspring (average of 0.16) compared to women belonging to the other genotype groups (average of 1.75 offspring, p = 1.4×10 -15 ). Notably, all homozygous women who had given birth had received infertility therapy. Moreover, our age-stratified analyses identified three additional genome-wide significant loci. Two loci were associated with early-onset disease (infertility diagnosed before age 30), located near CHEK2 and within the major histocompatibility complex (MHC)-region. The third locus, associated with late-onset disease, had its lead SNP located in an intron of a lncRNA gene. Taken together, our data highlight the significance of rare recessive alleles in shaping female infertility risk. The results further provide evidence supporting specific age-dependent mechanisms underlying this complex disorder.
- Top Cited PapersOpen Access
- 31 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Genome-wide association analysis of plasma lipidome identifies 495 genetic associations
The human plasma lipidome captures risk for cardiometabolic diseases. To discover new lipid-associated variants and understand the link between lipid species and cardiometabolic disorders, we perform univariate and multivariate genome-wide analyses of 179 lipid species in 7174 Finnish individuals. We fine-map the associated loci, prioritize genes, and examine their disease links in 377,277 FinnGen participants. We identify 495 genome-trait associations in 56 genetic loci including 8 novel loci, with a considerable boost provided by the multivariate analysis. For 26 loci, fine-mapping identifies variants with a high causal probability, including 14 coding variants indicating likely causal genes. A phenome-wide analysis across 953 disease endpoints reveals disease associations for 40 lipid loci. For 11 coronary artery disease risk variants, we detect strong associations with lipid species. Our study demonstrates the power of multivariate genetic analysis in correlated lipidomics data and reveals genetic links between diseases and lipid species beyond the standard lipids.
- 31 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Top Cited PapersOpen AccessGenome-wide association analysis of plasma lipidome identifies 495 genetic associations
The human plasma lipidome captures risk for cardiometabolic diseases. To discover new lipid-associated variants and understand the link between lipid species and cardiometabolic disorders, we perform univariate and multivariate genome-wide analyses of 179 lipid species in 7174 Finnish individuals. We fine-map the associated loci, prioritize genes, and examine their disease links in 377,277 FinnGen participants. We identify 495 genome-trait associations in 56 genetic loci including 8 novel loci, with a considerable boost provided by the multivariate analysis. For 26 loci, fine-mapping identifies variants with a high causal probability, including 14 coding variants indicating likely causal genes. A phenome-wide analysis across 953 disease endpoints reveals disease associations for 40 lipid loci. For 11 coronary artery disease risk variants, we detect strong associations with lipid species. Our study demonstrates the power of multivariate genetic analysis in correlated lipidomics data and reveals genetic links between diseases and lipid species beyond the standard lipids.
- Open Access
- 1 October 2023
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 16 (5) , 486-489
Phenotype of ASDs Associated With 4p16 Risk Locus and Novel Genome-Wide Associations of ASD Patients in the Finnish Population
- 1 October 2023
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 16 (5) , 486-489
Open AccessPhenotype of ASDs Associated With 4p16 Risk Locus and Novel Genome-Wide Associations of ASD Patients in the Finnish Population
- Open Access
- 26 May 2023
- Published by Springer Nature in Nature
- Vol. 618 (7965) , E19-E20
Author Correction: The power of genetic diversity in genome-wide association studies of lipids
- 26 May 2023
- Published by Springer Nature in Nature
- Vol. 618 (7965) , E19-E20
Open AccessAuthor Correction: The power of genetic diversity in genome-wide association studies of lipids
- Open Access
- 23 January 2023
- Published by Cold Spring Harbor Laboratory in medRxiv
Genome-wide association analysis of plasma lipidome identifies 495 genetic associations
Human plasma lipidome captures risk for cardio-metabolic diseases. To discover new lipid-associated variants and understand link between lipid species and cardiometabolic disorders, we performed univariate and multivariate genome-wide analyses of 179 lipid species in 7,174 Finnish individuals. We further fine-mapped the associated loci, prioritized genes, and examined their disease links in 377,277 FinnGen participants. We identified 495 genome-trait associations in 56 genetic loci including 9 novel loci, with a considerable boost provided by multivariate analysis. For 26 loci, fine-mapping identified variants with a high causal probability, including 14 coding variants indicating likely causal genes. Phenome-wide analysis across 953 disease endpoints in FinnGen revealed disease associations for 40 lipid loci. For 11 known coronary artery disease risk variants, we detected strong associations with lipid species. Our study demonstrates the power of multivariate genetic analysis in correlated lipidomics data and reveals genetic links between diseases and detailed lipid measures beyond standard lipids.
- 23 January 2023
- Published by Cold Spring Harbor Laboratory in medRxiv
Open AccessGenome-wide association analysis of plasma lipidome identifies 495 genetic associations
Human plasma lipidome captures risk for cardio-metabolic diseases. To discover new lipid-associated variants and understand link between lipid species and cardiometabolic disorders, we performed univariate and multivariate genome-wide analyses of 179 lipid species in 7,174 Finnish individuals. We further fine-mapped the associated loci, prioritized genes, and examined their disease links in 377,277 FinnGen participants. We identified 495 genome-trait associations in 56 genetic loci including 9 novel loci, with a considerable boost provided by multivariate analysis. For 26 loci, fine-mapping identified variants with a high causal probability, including 14 coding variants indicating likely causal genes. Phenome-wide analysis across 953 disease endpoints in FinnGen revealed disease associations for 40 lipid loci. For 11 known coronary artery disease risk variants, we detected strong associations with lipid species. Our study demonstrates the power of multivariate genetic analysis in correlated lipidomics data and reveals genetic links between diseases and detailed lipid measures beyond standard lipids.
- Open Access
- 18 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation
Inflammatory and infectious upper respiratory diseases (ICD-10: J30-J39), such as diseases of the sinonasal tract, pharynx and larynx, are growing health problems yet their genomic similarity is not known. We analyze genome-wide association to eight upper respiratory diseases (61,195 cases) among 260,405 FinnGen participants, meta-analyzing diseases in four groups based on an underlying genetic correlation structure. Aiming to understand which genetic loci contribute to susceptibility to upper respiratory diseases in general and its subtypes, we detect 41 independent genome-wide significant loci, distinguishing impact on sinonasal or pharyngeal diseases, or both. Fine-mapping implicated non-synonymous variants in nine genes, including three linked to immune-related diseases. Phenome-wide analysis implicated asthma and atopic dermatitis at sinonasal disease loci, and inflammatory bowel diseases and other immune-mediated disorders at pharyngeal disease loci. Upper respiratory diseases also genetically correlated with autoimmune diseases such as rheumatoid arthritis, autoimmune hypothyroidism, and psoriasis. Finally, we associated separate gene pathways in sinonasal and pharyngeal diseases that both contribute to type 2 immunological reaction. We show shared heritability among upper respiratory diseases that extends to several immune-mediated diseases with diverse mechanisms, such as type 2 high inflammation.
- 18 January 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-15
Open AccessInflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation
Inflammatory and infectious upper respiratory diseases (ICD-10: J30-J39), such as diseases of the sinonasal tract, pharynx and larynx, are growing health problems yet their genomic similarity is not known. We analyze genome-wide association to eight upper respiratory diseases (61,195 cases) among 260,405 FinnGen participants, meta-analyzing diseases in four groups based on an underlying genetic correlation structure. Aiming to understand which genetic loci contribute to susceptibility to upper respiratory diseases in general and its subtypes, we detect 41 independent genome-wide significant loci, distinguishing impact on sinonasal or pharyngeal diseases, or both. Fine-mapping implicated non-synonymous variants in nine genes, including three linked to immune-related diseases. Phenome-wide analysis implicated asthma and atopic dermatitis at sinonasal disease loci, and inflammatory bowel diseases and other immune-mediated disorders at pharyngeal disease loci. Upper respiratory diseases also genetically correlated with autoimmune diseases such as rheumatoid arthritis, autoimmune hypothyroidism, and psoriasis. Finally, we associated separate gene pathways in sinonasal and pharyngeal diseases that both contribute to type 2 immunological reaction. We show shared heritability among upper respiratory diseases that extends to several immune-mediated diseases with diverse mechanisms, such as type 2 high inflammation.
- Open Access
- 17 August 2022
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-16
Inframe insertion and splice site variants in MFGE8 associate with protection against coronary atherosclerosis
Cardiovascular diseases are the leading cause of premature death and disability worldwide, with both genetic and environmental determinants. While genome-wide association studies have identified multiple genetic loci associated with cardiovascular diseases, exact genes driving these associations remain mostly uncovered. Due to Finland’s population history, many deleterious and high-impact variants are enriched in the Finnish population giving a possibility to find genetic associations for protein-truncating variants that likely tie the association to a gene and that would not be detected elsewhere. In a large Finnish biobank study FinnGen, we identified an association between an inframe insertion rs534125149 inMFGE8(encoding lactadherin) and protection against coronary atherosclerosis. This variant is highly enriched in Finland, and the protective association was replicated in meta-analysis of BioBank Japan and Estonian biobank. Additionally, we identified a protective association between splice acceptor variant rs201988637 inMFGE8and coronary atherosclerosis, independent of the rs534125149, with no significant risk-increasing associations. This variant was also associated with lower pulse pressure, pointing towards a function ofMFGE8in arterial aging also in humans in addition to previous evidence in mice. In conclusion, our results suggest that inhibiting the production of lactadherin could lower the risk for coronary heart disease substantially.
- 17 August 2022
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-16
Open AccessInframe insertion and splice site variants in MFGE8 associate with protection against coronary atherosclerosis
Cardiovascular diseases are the leading cause of premature death and disability worldwide, with both genetic and environmental determinants. While genome-wide association studies have identified multiple genetic loci associated with cardiovascular diseases, exact genes driving these associations remain mostly uncovered. Due to Finland’s population history, many deleterious and high-impact variants are enriched in the Finnish population giving a possibility to find genetic associations for protein-truncating variants that likely tie the association to a gene and that would not be detected elsewhere. In a large Finnish biobank study FinnGen, we identified an association between an inframe insertion rs534125149 inMFGE8(encoding lactadherin) and protection against coronary atherosclerosis. This variant is highly enriched in Finland, and the protective association was replicated in meta-analysis of BioBank Japan and Estonian biobank. Additionally, we identified a protective association between splice acceptor variant rs201988637 inMFGE8and coronary atherosclerosis, independent of the rs534125149, with no significant risk-increasing associations. This variant was also associated with lower pulse pressure, pointing towards a function ofMFGE8in arterial aging also in humans in addition to previous evidence in mice. In conclusion, our results suggest that inhibiting the production of lactadherin could lower the risk for coronary heart disease substantially.